125 related articles for article (PubMed ID: 33039684)
21. "Decoding hereditary breast cancer" benefits and questions from multigene panel testing.
Colas C; Golmard L; de Pauw A; Caputo SM; Stoppa-Lyonnet D
Breast; 2019 Jun; 45():29-35. PubMed ID: 30822622
[TBL] [Abstract][Full Text] [Related]
22. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
23. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Chen LM; Richardson DL;
Gynecol Oncol; 2015 Jan; 136(1):3-7. PubMed ID: 25238946
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Pujol P; Vande Perre P; Faivre L; Sanlaville D; Corsini C; Baertschi B; Anahory M; Vaur D; Olschwang S; Soufir N; Bastide N; Amar S; Vintraud M; Ingster O; Richard S; Le Coz P; Spano JP; Caron O; Hammel P; Luporsi E; Toledano A; Rebillard X; Cambon-Thomsen A; Putois O; Rey JM; Hervé C; Zorn C; Baudry K; Galibert V; Gligorov J; Azria D; Bressac-de Paillerets B; Burnichon N; Spielmann M; Zarca D; Coupier I; Cussenot O; Gimenez-Roqueplo AP; Giraud S; Lapointe AS; Niccoli P; Raingeard I; Le Bidan M; Frebourg T; Rafii A; Geneviève D
Eur J Hum Genet; 2018 Dec; 26(12):1732-1742. PubMed ID: 30089825
[TBL] [Abstract][Full Text] [Related]
25. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
26. Optimization of the diagnosis of inherited colorectal cancer using NGS and capture of exonic and intronic sequences of panel genes.
Baert-Desurmont S; Coutant S; Charbonnier F; Macquere P; Lecoquierre F; Schwartz M; Blanluet M; Vezain M; Lanos R; Quenez O; Bou J; Bouvignies E; Fourneaux S; Manase S; Vasseur S; Mauillon J; Gerard M; Marlin R; Bougeard G; Tinat J; Frebourg T; Tournier I
Eur J Hum Genet; 2018 Nov; 26(11):1597-1602. PubMed ID: 29967336
[TBL] [Abstract][Full Text] [Related]
27. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
28. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
[TBL] [Abstract][Full Text] [Related]
29. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of related genes in hamartoma polyp tissue of Peutz-Jeghers syndrome.
Zhang Z; Duan FX; Gu GL; Yu PF
World J Gastroenterol; 2020 Apr; 26(16):1926-1937. PubMed ID: 32390703
[TBL] [Abstract][Full Text] [Related]
31. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
[TBL] [Abstract][Full Text] [Related]
32. [Retrospective NGS Study in High-risk Hereditary Cancer Patients at Masaryk Memorial Cancer Institute].
Macháčková E; Hazova J; Sťahlová Hrabincová E; Vašíčková P; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2016; 29 Suppl 1():S35-45. PubMed ID: 26691941
[TBL] [Abstract][Full Text] [Related]
33. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Slavin TP; Niell-Swiller M; Solomon I; Nehoray B; Rybak C; Blazer KR; Weitzel JN
Front Oncol; 2015; 5():208. PubMed ID: 26484312
[TBL] [Abstract][Full Text] [Related]
34. Disease spectrum of gastric cancer susceptibility genes.
McKinley SK; Singh P; Yin K; Wang J; Zhou J; Bao Y; Wu M; Pathak K; Mullen JT; Braun D; Hughes KS
Med Oncol; 2021 Mar; 38(5):46. PubMed ID: 33760988
[TBL] [Abstract][Full Text] [Related]
35. A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing.
Krahn M; Biancalana V; Cerino M; Perrin A; Michel-Calemard L; Nectoux J; Leturcq F; Bouchet-Séraphin C; Acquaviva-Bourdain C; Campana-Salort E; Molon A; Urtizberea JA; Audic F; Chabrol B; Pouget J; Froissart R; Melki J; Rendu J; Petit F; Métay C; Seta N; Sternberg D; Fauré J; Cossée M
Eur J Hum Genet; 2019 Mar; 27(3):349-352. PubMed ID: 30552423
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of laboratory perspectives on hereditary cancer panels.
Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ
Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169
[TBL] [Abstract][Full Text] [Related]
37. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA
BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
[TBL] [Abstract][Full Text] [Related]
39. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
40. Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.
Alqahtani M; Edwards C; Buzzacott N; Carpenter K; Alsaleh K; Alsheikh A; Abozeed W; Mashhour M; Almousa A; Housawi Y; Al Hawwaj S; Iacopetta B
Fam Cancer; 2018 Apr; 17(2):197-203. PubMed ID: 28643016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
